Multiple Myeloma Expert Roundtable: Stem Cell Transplantation, Maintenance Therapy, and Relapsed/Refractory Disease

Access Activity

Overview / Abstract:

With numerous recent advances in available treatments and options for diagnosis and staging, disease monitoring, and supportive care, the outlook for patients with multiple myeloma has never been brighter. However, this expansion of clinical options has also introduced potentially daunting challenges for the health care providers charged with the care of these patients.

This activity presents a robust roundtable discussion in which our expert faculty provides insights on such issues as determining the optimal timing and approach for autologous stem cell transplantation (ASCT), considering new factors when weighing the benefits and risks of maintenance therapy, and choosing between the various therapeutic options in the relapsed/refractory setting. This activity includes downloadable resources (including supplemental figures and tables).


Dec 27, 2018


Nurse Practitioner , Physician CME, Physician Assistant CME



Credits / Hours

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine, RedMedEd, and the Multiple Myeloma Research Foundation. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.Penn State College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Presenters / Authors / Faculty

Amrita Y. Krishnan, MD
Professor, Department of Hematology & Hematopoietic Cell Transplantation
Director, Judy and Bernard Briskin Center for Multiple Myeloma Research
City of Hope Medical Center
Duarte, California

Gareth J. Morgan, MD, PhD
Professor of Medicine
Director, Myeloma Institute
Deputy Director, Winthrop P. Rockefeller Cancer Institute
University of Arkansas for Medical Sciences Myeloma Institute
Little Rock, Arkansas

Saad Z. Usmani, MD, FACP
Director, Plasma Cell Disorders Program
Director, Clinical Research in Hematologic Malignancies
Department of Hematologic Oncology & Blood Disorders
Levine Cancer Institute
Charlotte, North Carolina

Activity Specialities / Related Topics

Education / Teaching, Hematology, Oncology / Cancer / Radiation Therapy

Sponsors / Supporters / Grant Providers

Support for this activity has been provided through educational grants from Amgen, Celgene Corporation, and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Keywords / Search Terms

RedMedEd RedMedEd, MMRF, MM, multiple myeloma, stem cell transplantation, maintenance therapy, relapsed/refractory disease, relapsed/refractory MM, oncology, hematology, Free, CME, CE, multiple myeloma patients, ASCT, autologous stem cell transplantation, novel agent, monoclonal antibody Free CE CME

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.